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CARTILAGE SHOWS DIFFERENT GENE-EXPRESSION PROFILES RELATED
TO BOTH INFLAMMATORY AND IMMUNE RESPONSE PROCESSES
J. Fernández-Tajes, A. Soto-Hermida, M. Fernández-Moreno, M.E. Vázquez-
Mosquera, N. Oreiro-Villar, C. Fernández-López, E. Cortés-Pereira,
S. Relaño-Fernández, I. Rego-Pérez, F.J. Blanco. INIBIC-CHUAC, Genomic
Group. Rheumatology Div.., A Coruña, Spain
Purpose: To perform a genome-wide expression assay in order to identify
different expression proﬁles in the OA disease
Methods: Total RNA from OA cartilage samples was isolated with RNeasy
Kit (Qiagen, Madrin, Spain) following manufacturer’s instructions. RNA
was checked for integrity and purity with the Agilent Bioanalyzer (Agilent
Technologies) and NanoDrop spectrophotometer (Thermo Scientiﬁc). 150
nanograms of total RNA were used for cDNA synthesis using the Ambion
WT Expression kit (Ambion). The fragmented cDNAwas hybridized against
the Human Gene 1.1 ST array strip (Affymetrix) and scanned using the
GeneTitan system (Affymetrix). Quality controls, normalization, pre-pro-
cessing, differential gene expression and functional analyses were carried
out with Bioconductor packages using R software.
Results: Human Gene 1.1 ST Array, which interrogates more than 28,000
well-annotated genes of 33,297 probes, was used for studying the genome
wide expression proﬁle of 23 OA-patients tissue samples. A non-speciﬁc
ﬁltering was previously applied for removing those probes with non-
annotation information and with low intra-array variation. An unsuper-
vised machine learning approach revealed a group of samples highly
different (Figure 1). The differential expression analysis between this
cluster, comprising a total of ﬁve OA-patients, and the rest of the samples
allowed for the identiﬁcation of 176 differentially expressed probes with
an adjusted p value below 0.0001. The 20 differentially expressed probes
with higher log Fold Change are presented in Table 1. The analysis of the
biological processes related to these differentially expressed genes showed
that inﬂammation and immune processes were the main pathways found
to be altered when a gene set enrichment analysis was applied.
Conclusions: The genome-wide expression analysis shows a clearly
distinct proﬁle for a group of OA patients. Both inﬂammation and immune
response processes appeared to be altered and therefore are revealed as
key factors in the development of the OA disease.Ă397
IDENTIFICATION OF THE PATHOGENIC PATHWAYS IN OSTEOARTHRITIC
HIP CARTILAGE: COMMONALITY AND DISCORD BETWEEN HIP AND
KNEE OA
Y. Xu, M.J. Barter, D.C. Swan, K.S. Rankin, A.D. Rowan, M. Santibanez-
Koref, J. Loughlin, D.A. Young. Newcastle Univ., Newcastle upon Tyne,
United Kingdom
Purpose: To deﬁne for the ﬁrst time the transcriptome of normal and end-
stage osteoarthritic (OA) hip cartilage and to identify novel pathogenic
pathways involved in the disease.
Methods: RNA was isolated from articular cartilage samples obtained from
consented patients undergoing joint replacement surgery due to either end-
stage hip OA or neck of femur fracture (NOF). Illumina HumanHT-12 V3
whole genome expression arrayswere used to proﬁle gene expressions. Raw
data was analyzed and differentially expressed genes identiﬁed using the
Agilent Gene Spring GX 11 package. P-values were corrected for multiple
testing using the Benjamini-Hochberg method. Gene Set Enrichment Anal-
ysis (GSEA) and Ingenuity Pathway Analysis (IPA) were used to investigate
functions and pathways associated with these genes, respectively. Protein
interaction networks were predicted using STRING and visualized with
Medusa 3.0. Differentially expressed genes were veriﬁed by real-time PCR.
Results: In total we identiﬁed 1151 differentially expressed genes (fold
change  -1.5 or 1.5, P-value  0.01) between NOF (n¼10) and OA hip
(n¼9) cartilage. Sixty canonical pathways (P-value  0.05) were identiﬁed
as associated with these genes. A comparison between a published
comparable knee dataset only identiﬁed 183 genes similarly differentially
expressed but remarkably 35 canonical pathways overlapped between the
experiments. wnt/b-catenin signalling, PI3K/AKT signalling and IL-17 sig-
nalling pathways were identiﬁed in common between both studies.
Pathways such as glycosaminoglycan degradation (P-value¼0.044), HIF1a
signalling (P-value¼0.007) and interferon signalling (P-value¼0.003),
were speciﬁc to our hip OA study, while IGF-1 signalling, clathrin-medi-
ated endocytosis signalling and HMGB1 signalling were only associated
with the differentially expressed genes from knee OA cartilage.
Conclusions: This is the ﬁrst study to report a comprehensive gene
expression analysis of human hip OA cartilage compared to control (neck
of femur fracture) cartilage at the whole human genome level. Our
differential gene expression dataset shows excellent correlation with
similar deﬁned studies using comparable tissue but reveals discord
between hip and knee OA in the behavior of individual genes although
commonality with respect to the molecular pathways involved.
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MICROARRAY ANALYSIS OF GENE EXPRESSION IN PRIMARY HUMAN
OSTEOBLASTS DERIVED FROM SPINE
F. Moldovan, K. Fendri, S. Parent, C. Zaouter, A. Moreau,
K.S. Patten. Montreal Univ., Montreal, QC, Canada
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S198Purpose: Adolescent idiopathic scoliosis (AIS) is the most common form of
spinal deformity. It occurs primarily in girls and progresses during pre-
pubertal and pubertal growth, a crucial period for bone mass acquisition.
The aetiology andmolecularmechanisms of AIS are not clear; currently the
consensus is that AIS has a multifactor aetiology, but the involvement of
genetic factors is widely accepted. During the past ﬁve years, considerable
effort has been devoted to identify a gene or genes that cause a predispo-
sition to AIS. Many loci for AIS have been mapped to different chromosome
regions but no genes have yet been clearly identiﬁed as responsible for AIS
or involved in pathogenesis of AIS. In this study, we used a microarray
approach and real-time RT-PCR. (qPCR) to establish a global gene
expression proﬁle of primary human osteoblasts derived from spinal
vertebrae of AIS and control patients.
Methods: Gene expression proﬁling was investigated by microarray
analysis in RNA samples isolated from osteoblasts derived from healthy
and AIS individuals (n¼12). RNA samples were extracted from osteoblasts,
puriﬁed, ﬂuorescently labelled, and then hybridized to gene expression
microarrays using the Illumina expression BeadChips technology con-
taining more than 46,000 probes for the human genome (HumanHT-12).
Data analysis in R version 2.10.1 (Bioconductor packages oligo and limma)
was performed and genes that had at least 1.5-fold change in expression
were considered differentially regulated relative to controls.The expres-
sion levels of a subset of up- and down-regulated genes in AIS compared to
controls were evaluated with RT-qPCR analysis to verify regulation as
assessed by microarray analysis.
Results: Our microarray results show that speciﬁc subsets of genes are
differentially expressed in AIS, which was conﬁrmed for the most part by
reverse-transcription-quantitative PCR (RT-qPCR). Furthermore, we
observe that the differentially regulated genes could be grouped and
assigned to various functional categories, indicating that many regulatory
pathways could be involved in AIS pathogenesis. In the present work, we
have used gene expression proﬁling to identify differentially expressed
genes in AIS compared with non-AIS osteoblasts. Our study provides
a previously unrecognized list of genes and related potential pathways that
merit further investigation, such as identiﬁcation of variants (mutants or
SNPs) in these genes, as putative AIS causative genes. These genes were
grouped in terms of their biological function, and clustered by gene-gene
interactions. We identiﬁed at least 4 particular pathways that might be
important in AIS: the developmental/growth-differentiation of skeletal
elements (HOXB8, HOXA2, HOXB2, MEOX2 and PITX1); cellular signaling
(HOXA11 and BARX1), connecting structural integrity of the extracellular
matrix to the structural integrity of a bone or a muscle ﬁber (COMP, HOXA2
and HOXA11); and cellular signaling and cartilage damage (GDF15).
Conclusions: Taken together, our study has demonstrated gene expression
changes in osteoblasts from AIS patients, as compared to osteoblasts from
healthy controls. The reported results help to gain further insight into
potential genes and molecular pathways that could contribute to under-
standing the pathophysiology of idiopathic scoliosis. These results show
that a speciﬁc subset of target genes is involved in AIS, including new
genes, not previously known to be associated with AIS. We found signiﬁ-
cant difference of up- and down-regulated) genes when control and AIS
patients were compared. Those genes concern various regulatory path-
ways that could interplay in pathogenesis of AIS. Our study pointed out
some of the putative causative genes of AIS.
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ALLELIC EXPRESSION ANALYSIS OF THE OSTEOARTHRITIS
SUSCEPTIBILITY LOCUS THAT MAPS TO MICAL3
M. Ratnayake, L.N. Reynard, E.V. Raine, M. Santibanez-Koref,
J. Loughlin. Newcastle Univ., Newcastle upon Tyne, United Kingdom
Purpose: A genome-wide association scan with subsequent replication
study that involved over 67,000 individuals of European ancestry
produced evidence of an association of the single nucleotide poly-
morphism (SNP) rs2277831 to primary OA, with a p-value of 3x10-5.
rs2277831 is an A/G transition located within an intron of the gene
MICAL3, which maps to chromosome 22q11.21. The association interval
marked by rs2277831 encompasses two additional genes, BCL2L13 and
BID. It is becoming increasingly apparent that many common complex
traits are mediated by cis-acting regulatory polymorphisms that inﬂuence,in a tissue-speciﬁc manner, gene transcription or transcript stability,
resulting in allelic expression imbalance. In this study we therefore used
total and allelic expression analysis to assess whether the OA association to
rs2277831 is mediated by an inﬂuence on MICAL3, BCL2L13 or BID
expression.
Methods: Using RNA extracted from the cartilage, fat pad, synovium and
cancellous bone of OA patients who had undergone elective joint
replacement surgery, we assessed whether rs2277831 correlated with
allelic expression of either of the three genes by: 1) measuring the
expression of each gene by quantitative PCR and then stratifying the data
by genotype at rs2277831 and 2) accurately discriminating and quanti-
fying the mRNA synthesized from the alleles of OA patients using allelic-
quantitative PCR. In this latter analysis, we studied patients who were
compound heterozygotes for rs2277831 and for transcript SNPs from
within each gene. Linear regression was used to assess whether gene
expression relative to genotype differed signiﬁcantly from the null, whilst
a 2-tailed Mann-Whitney exact test was used to assess the signiﬁcance of
any allelic differences. We studied a total of 60 male and female patients,
who had undergone either a hip or a knee replacement.
Results:We found no evidence for a correlation between gene expression
and genotype at rs2277831, with p-values of 0.31 for BCL2L13, 0.13 for BID
and 0.66 for MICAL3. In the allelic expression analysis we observed several
examples of signiﬁcant (p < 0.05) allelic imbalances, with the most
extreme case being at MICAL3, with an allelic expression ratio of 5.47 in
the cartilage of a male patient with knee OA. However, there was no
correlation observed between the pattern of allelic expression and the
association signal marked by rs2277831.
Conclusions: In the tissues that we have studied, our data does not
support the OA association signal that is marked by SNP rs2277831 as
mediating an effect on the expression of MICAL3, BCL2L13 or BID. Other
functional effects presumably account for this association signal.
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REGULATION OF THE INCREASED N-CADHERIN LEVELS IN
OSTEOARTHRITIS SYNOVIAL FIBROBLASTS
A. Ruedel 1,2, K. Stark 1,3, A.K. Bosserhoff 1,2. 1Univ. of Regensburg,
Regensburg, Germany; 2 Pathology, Molecular Pathology, Regensburg,
Germany; 3 Internal Med. II, Regensburg, Germany
Purpose: Osteoarthritis (OA) is the most common form of arthritis and is
characterized by the destruction of cartilage. OA ﬁbroblasts of the synovial
membrane are activated and are then, to some extent, able to migrate into
the cartilage and destroy it. To identify differences between OASF and
healthy synovial ﬁbroblasts (SF) the mRNA expression pattern of known
migration affecting genes, e.g. adhesion molecules were analyzed and we
found that N-cadherin expression was highly increased in SF of OA
patients. N-cadherin is known to inﬂuence migration of tumor cells in
a positive or negative way, e.g. in malignant melanomas or osteosarcomas,
respectively. For further analysis the N-cadherin promoter was screened
for differences in OASF compared to SF from healthy donors.
Methods: mRNA expression of OASF and healthy SF was analyzed by qRT-
PCR. Single nucleotide polymorphisms (SNP) in the genomic region of
CDH2 were identiﬁed and patient and control samples were genotyped
using 5' exonuclease TaqMan technology (Life Technologies, Applied
Biosystems). To measure the different binding potential of transcription
factors to the variants electrophoretic mobility shift assays (EMSA),
enzyme-linked immunosorbent assays (ELISA) and chromatin immuno-
precipitation (ChIP) were performed using ETS-1 antibodies. For the latter,
products binding to the different SNP variants were distinguished via PCR
and sequencing.
Results: We identiﬁed a SNP in the promoter, which is associated with
a positive outcome for OA patients. This rare SNP leads to the formation of
new transcription factor binding sites and to an even more increased
N-cadherin expression. Calculations using the SNPInspector tool
(Genomatix Software GmbH) revealed two possible transcription factors
which could bind to the altered binding site, ETS-1 and zinc ﬁnger protein
35 (ZNF35). In order to identify the transcription factor responsible for the
increased N-cadherin levels, several assays were performed. The ETS-1
antibody resulted in a clear supershift in the EMSAs but no difference in
binding efﬁciency between the probes of the two variants was observed.
